Pituitary Apoplexy: Comorbidities, Management and Outcomes. A Spanish Observational Multicenter Study.
Betina BiagettiEsteban Cordero AsanzaCarlos Pérez-LópezMarta Araujo-CastroRosa CamaraFernando Guerrero-PérezAlmudena VicenteCristina Lamas OliveiraGuillermo SerraAna Irigaray EcharriM Dolores OlleroInmaculada González MoleroRocío Villar-TaiboMaría Dolores Moure RodríguezPablo García-FeijooVíctor Rodríguez BerrocalMaría Noelia Sánchez RamirezAlba Gutiérrez HurtadoVanessa Capristan-DíazAndreu Simó-ServatMarta GallachEva Safont PerezVictoria González RosaSoralla CivantosDiego Asensio-WandosellElena Martinez-SaezEdelmiro Menéndez TorreAnna AulinasPedro IglesiasJuan J DiezIgnacio BernabéuCristina Álvarez-EscoláManel Puig-DomingoPublished in: The Journal of clinical endocrinology and metabolism (2024)
There is a high burden of cardiovascular risk factors among patients with PA suggesting that metabolic factors may play a potential role in the development of PA. This underscores the need for comprehensive management of these conditions in addition to treating the apoplexy itself in this population. Surgical management has a relevant place in PA approach mainly in patients with higher PAS. However, it leads permanent vasopressin deficit more frequently than conservative approach.